Trxade Group, Inc. (MEDS:NASDAQ) jumped higher at $10.69, a gain of 61.5%. On Wed, Aug 02, 2023, MEDS:NASDAQ touched a New 2-Week High of $10.69. The stock got featured on our News Catalysts scanner on Mon, Jul 31, 2023 at 04:41 PM in the 'EARNINGS' category. From Wed, Jul 19, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Aug 02, 2023 at $13.44 with a volume of 8M+.
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- WaveDancer Inc. (WAVD:NASDAQ), 95.95%
- Lottery.com Inc. (LTRY:NASDAQ), 88.07%
- Trxade Group, Inc. (MEDS:NASDAQ), 61.48%
- Aurora Acquisition Corp. (AURC:NASDAQ), 59.94%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 54.29%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 41.8%
- Powell Industries, Inc. (POWL:NASDAQ), 39.57%
- Alset Capital Acquisition Corp. (ACAX:NASDAQ), 39.22%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 33.98%